Clinical TrialsSearch results
Number of results: 596
Completed
- Post remission therapy including arsenic trioxide against acute promylocytic leukemia (APL) in elderly patients. (JALSG APL212G study)
- Adult acute promylocytic leukemia
- Takeshita Akihiro
- 2019-03-14
Recruiting
- Positive end-expiratory pressure during pneumoperitoneum changes the Electrical Impedance Tomography ventilation distribution in pediatric patients.
- Pediatric patients (2-12 years old) undergoing laparoscopic inguinal hernia surgery
- Yagihara Masahiro
- 2024-01-26
Other
- Placebo-controlled comparative study of NPC-12Y oily gel in patients with skin lesions associated with tuberous sclerosis complex
- Tuberous Sclerosis Complex
- Fujimoto Ayataka
- 2022-08-10
Other
- Pilot study on intersegmental line identification during lung segmentectomy by video pulse wave extraction technology using non-contact vital sensing software
- Metastatic lung tumor, Primary lung cancer
- Ohde Yasuhisa
- 2024-05-16
Other
- PhaseIII study of gefitinib versus cisplatin plus docetaxel in patients with non-small cell lung cancer with EGFR mutation
- non small cell lung cancer
- West Japan Oncology Group
- 2006-12-11
Other
- PhaseII study of Atezolizumab plus Chemotherapy in PS 2 Patients With Non-Sq NSCLC
- Non-Sq non-small cell lung cancer
- Murakami Haruyasu
- 2021-06-10
Other
- Phase2/3 Study of OTS102 in Combination With Gemcitabine in Patients With Unresectable Advanced Pancreatic Cancer and Recurrent Pancreatic Cancer(PEGASUS-PC Study)
- Unresectable Advanced and Recurrent Pancreatic Cancer
- OncoTherapy Science, Inc.
- 2009-01-27
Recruiting
- Phase1/2 study of endoscopic photodynamic therapy using ME2906 and ultrathin PDT probe in unresectable bile duct cancer
- Unresectable bile duct cancer
- Sato Junya
- 2023-01-16
Recruiting
- Phase two clinical trial of limited stage lymphoblastic lymphoma.
- Limited stage lymphoblastic lymphoma
- Japanese Pediatric Leukemia/Lymphoma Study Group(JPLSG)
- 2009-07-26
Other
- Phase III trial of doxorubicin / cyclophosphamide (AC), docetaxel (D), and alternating AC and D (AC-D) as front-line chemotherapy for metastatic breast cancer: Japan Clinical Oncology Group trial (JCOG9802)
- Patients with Metatatic Breast Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-09-12